News & Events

FDA News Release

FDA takes action to stop the use of lead acetate in hair dyes

For Immediate Release

October 30, 2018

Release

Español

The U.S. Food and Drug Administration today took action to remove lead acetate in hair coloring products given potential safety concerns about lead exposure from these products.

The agency issued a final rule in response to a color additive petition that repeals the regulation that allows for the use of lead acetate as a color additive in these products. This rule, when effective, removes the only authorization for the use of lead as an ingredient in cosmetic products.

“Today’s action is part of our commitment to protect Americans by reducing exposure to toxic elements and builds upon federal efforts to reduce exposure to lead,” said FDA Commissioner Scott Gottlieb, M.D. “In the nearly 40 years since lead acetate was initially approved as a color additive, our understanding of the hazards of lead exposure has evolved significantly. We now know that the approved use of lead acetate in adult hair dyes no longer meets our safety standard. Lead exposure can have serious adverse effects on human health, including for children who may be particularly vulnerable. Moreover, there are alternative color additives for hair coloring products that consumers can use that do not contain lead as an ingredient.”

This action is based on new scientific data that show there is no longer a reasonable certainty that there is no harm from the use of lead acetate as a color additive. In 1980, based on information presented in a color additive petition, the FDA originally permitted the use of lead acetate as a color additive in certain hair dye products that are typically applied over a period of time to achieve a gradual coloring effect. Because of this gradual effect, these products are sometimes referred to as “progressive” hair dyes.

Generally speaking, a color additive must be shown to be safe before it may be used to color foods, drugs, cosmetics, or certain medical devices. A color additive petition may be submitted to the FDA seeking to authorize a new use of a color additive by demonstrating the safety of its use.

Likewise, a color additive petition may be submitted to the FDA demonstrating that an authorized use of a color additive is no longer safe. If the FDA determines that the petition questioning the safety of an authorized color additive and other relevant information support the petitioned request, the agency will grant the request by repealing or amending the authorizing regulation. 

Today’s action is in response to a color additive petition. Based on this petition and other relevant information, the FDA concluded that there is no longer a reasonable certainty of no harm from the approved use of lead acetate in hair coloring products. This decision takes into account that, according to the U.S. Centers for Disease Control and Prevention, there is no safe exposure level for lead; there were deficiencies identified in a 1980 study estimating exposure to lead from hair dye that originally supported its use; and the fact that blood lead levels in the U.S. have dropped significantly since 1980, so we no longer can conclude that potential exposure to lead from lead acetate-containing hair dyes is insignificant.

The FDA is exercising enforcement discretion for a period of 12 months from the effective date of the final rule regarding hair dye products that contain lead acetate to allow firms to reformulate products.

Consumers wishing to avoid these products during that time can identify the products by the listing of lead acetate as an ingredient and by the presence of the warning label – that states, in part: “For external use only. Keep this product out of children’s reach.” Some manufacturers have already begun to reformulate their products with another color additive that does not contain lead as an ingredient, bismuth citrate.

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

###

Inquiries

Media

 Megan McSeveney
 240-402-4514


Consumers

 888-INFO-FDA

Page Last Updated: 10/31/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English